Labeler
Cipla USA Inc. NDC Codes
Cipla USA Inc. lists 269 finished drug products in the FDA NDC Directory under NDC labeler code 69097.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Lanreotide Acetate, Diltiazem Hydrochloride, Lenalidomide, Lurasidone Hydrochloride, Pomalidomide, Phytonadione, Pravastatin Sodium, Fluticasone propionate and Salmeterol, Nilotinib, Potassium Phosphates, Vilazodone hydrochloride, Pirfenidone, Deferasirox, Lanthanum carbonate, Dapagliflozin
- Active ingredients
- Lanreotide acetate, Diltiazem hydrochloride, Lenalidomide, Lurasidone hydrochloride, Pomalidomide, Phytonadione, Pravastatin sodium, Fluticasone propionate, Salmeterol xinafoate, Nilotinib, Monobasic potassium phosphate, Dibasic potassium phosphate
- NDC labeler codes
- 69097
- Strengths (from the 100 most recently listed products)
- Salmeterol xinafoate 50 ug/1; Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL; Liraglutide 6 mg/mL; Lanreotide acetate 120 mg/.5mL; Lanreotide acetate 60 mg/.2mL; Lanreotide acetate 90 mg/.3mL; Phytonadione 1 mg/.5mL; Pirfenidone 267 mg/1; Cyclosporine .5 mg/mL; Pomalidomide 4 mg/1; Pomalidomide 1 mg/1; Pomalidomide 2 mg/1; Pomalidomide 3 mg/1; Fluticasone propionate 100 ug/1; Fluticasone propionate 250 ug/1; Fluticasone propionate 500 ug/1; Albuterol sulfate 90 ug/1; Dapagliflozin propanediol 5 mg/1; Dapagliflozin propanediol 10 mg/1
- Dosage forms
- Capsule, Tablet, Film coated, Injection, Tablet, Tablet, Extended release, Powder, Injection, Solution, Injection, Emulsion, For suspension, Granule, Tablet, Chewable, Emulsion, Kit, Suspension, Tablet, Film coated, Extended release, Tablet, Coated, Aerosol, Metered, Injection, Powder, Lyophilized, For suspension, Gel, Granule, For solution, Solution
- Routes
- Oral, Subcutaneous, Intravenous, Intramuscular, Respiratory (Inhalation), Ophthalmic, Topical
- Drug classes (FDA established)
- Thalidomide Analog, Somatostatin Analog, Osmotic Laxative, Potassium Salt, Calcium Channel Blocker, beta2-Adrenergic Agonist, Kinase Inhibitor, Atypical Antipsychotic, Corticosteroid, Vitamin K, Warfarin Reversal Agent, HMG-CoA Reductase Inhibitor, Proton Pump Inhibitor, Protease Inhibitor, Pyridone, Iron Chelator, Phosphate Binder, Sodium-Glucose Cotransporter 2 Inhibitor, GLP-1 Receptor Agonist, Leukocyte Growth Factor, P2Y12 Platelet Inhibitor, Serotonin Reuptake Inhibitor, Serotonin-4 Receptor Agonist, Dihydropyridine Calcium Channel Blocker, Aminoketone, Androgen, Nucleoside Metabolic Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Calcineurin Inhibitor Immunosuppressant, Microtubule Inhibitor, Penicillin-class Antibacterial, beta Lactamase Inhibitor, Calcitonin, Nonsteroidal Anti-inflammatory Drug, Muscle Relaxant, Neuraminidase Inhibitor, Cytochrome P450 3A Inhibitor, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 136 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Nadolol | Nadolol 20 mg/1 | TabletOral | 69097-867 | 69097-0867-0269097-0867-0769097-0867-15 | — |
| Nadolol | Nadolol 40 mg/1 | TabletOral | 69097-868 | 69097-0868-0269097-0868-0769097-0868-15 | — |
| Nadolol | Nadolol 80 mg/1 | TabletOral | 69097-869 | 69097-0869-0269097-0869-0769097-0869-15 | — |
| Celecoxib | Celecoxib 200 mg/1 | CapsuleOral | 69097-421 | 69097-0421-0269097-0421-0769097-0421-12+1 more | — |
| Celecoxib | Celecoxib 400 mg/1 | CapsuleOral | 69097-420 | 69097-0420-0269097-0420-0369097-0420-11+1 more | — |
| Celecoxib | Celecoxib 100 mg/1 | CapsuleOral | 69097-422 | 69097-0422-0269097-0422-0769097-0422-12+1 more | — |
| Celecoxib | Celecoxib 50 mg/1 | CapsuleOral | 69097-423 | 69097-0423-0269097-0423-03 | — |
| Topiramate | Topiramate 25 mg/1 | TabletOral | 69097-122 | 69097-0122-0369097-0122-1269097-0122-15 | — |
| Topiramate | Topiramate 50 mg/1 | TabletOral | 69097-123 | 69097-0123-0369097-0123-1269097-0123-15 | — |
| Topiramate | Topiramate 100 mg/1 | TabletOral | 69097-124 | 69097-0124-0369097-0124-1269097-0124-15 | — |
| Topiramate | Topiramate 200 mg/1 | TabletOral | 69097-125 | 69097-0125-0369097-0125-1269097-0125-15 | — |
| Alendronate Sodium | Alendronate sodium 35 mg/1 | TabletOral | 69097-223 | 69097-0223-1669097-0223-76 | — |
| Alendronate Sodium | Alendronate sodium 70 mg/1 | TabletOral | 69097-224 | 69097-0224-1669097-0224-76 | — |
| Ipratropium Bromide and Albuterol Sulfate | Albuterol sulfate 2.5 mg/3mL; Ipratropium bromide .5 mg/3mL | SolutionRespiratory (Inhalation) | 69097-173 | 69097-0173-5369097-0173-64 | — |
| Amlodipine Besylate | Amlodipine besylate 5 mg/1 | TabletOral | 69097-127 | 69097-0127-0569097-0127-15 | — |
| Amlodipine Besylate | Amlodipine besylate 2.5 mg/1 | TabletOral | 69097-126 | 69097-0126-0569097-0126-15 | — |
| Amlodipine Besylate | Amlodipine besylate 10 mg/1 | TabletOral | 69097-128 | 69097-0128-0569097-0128-15 | — |
| Meloxicam | Meloxicam 15 mg/1 | TabletOral | 69097-159 | 69097-0159-0769097-0159-1269097-0159-15 | — |
| Meloxicam | Meloxicam 7.5 mg/1 | TabletOral | 69097-158 | 69097-0158-0769097-0158-1269097-0158-15 | — |
Cipla USA Inc.: common questions
- What is Cipla USA Inc.'s NDC labeler code?
- 69097. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Cipla USA Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.